Ling Li

8PUBLICATIONS

45CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMedical mycologyMolecular targetsHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 26, 2026

Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

|Dec 02, 2025

DDX6 undergoes phase separation to modulate metabolic plasticity and chemoresistance.

Hongjie Bi, Wei Li, Lili Ren

|Feb 01, 2025

miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape.

Fang Chen, Dandan Zhao, Yongfang Xu

|Feb 27, 2024

Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity.

Haojie Dong, Xin He, Lei Zhang

|Nov 28, 2023

Correction: TET2 deficiency promotes MDS-associated leukemogenesis.

Feiteng Huang, Jie Sun, Wei Chen

|Sep 01, 2023

Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis.

Bin Zhang, Dandan Zhao, Fang Chen

Pageof 2

Frequent Collaborators

Guido Marcucci

Ya-Huei Kuo

Jianjun Chen

Bin Zhang

Rui Su

Feiteng Huang

Michael A Caligiuri

Yong Liang

Russell Rockne

Jianhua Yu

Frequent Collaborators

Guido Marcucci

Ya-Huei Kuo

Jianjun Chen

Bin Zhang